Welcome to our dedicated page for Cadre Hldgs SEC filings (Ticker: CDRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cadre Holdings, Inc. SEC filings document the company's safety-equipment business, public-company governance and NYSE-listed common stock. Form 8-K reports cover operating results, financial condition, Regulation FD presentations, material events and related exhibits for its law enforcement, first responder, military and nuclear safety markets.
Cadre's filings also include proxy materials for annual meeting matters, board and stockholder voting procedures, and corporate governance disclosures. Financial-result filings discuss GAAP measures alongside non-GAAP metrics such as EBITDA, adjusted EBITDA and adjusted EBITDA margin, while event reports address material agreements, acquisition-related communications, capital-structure disclosures and security registration details for CDRE common stock.
Cadre Holdings, Inc. (CDRE) reported an insider transaction on Form 4. The company’s President sold 4,132 shares of common stock at $43 on 10/24/2025.
Following the sale, the reporting person directly owns 106,089 shares. The filing notes the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025.
CDRE filed a Form 144 notice for a proposed sale of 4,132 common shares through UBS Financial Services, with an aggregate market value of $177,676.00. The filing lists an approximate sale date of 10/24/2025 on the NYSE.
The shares were acquired as RSUs on 03/18/2024 from the issuer. As context, 40,663,844 shares were outstanding. The filer, identified as Brad Williams, reported sales in the past three months of 4,132 shares on 09/23/2025 for $152,884.00 and 4,132 shares on 10/14/2025 for $165,280.00.
Cadre Holdings (CDRE) filed a Form 4 showing an officer sale. On 10/14/2025, the company’s President sold 4,132 shares of Common Stock at $40 per share, coded “S.” The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025. Following the sale, the officer beneficially owns 110,221 shares directly.
Cadre Holdings, Inc. plans to host an investor day event at the New York Stock Exchange in New York City on October 8, 2025, beginning at 10:00 a.m. Eastern Time. Company management will give a slide presentation followed by a question-and-answer session.
The event will be broadcast live and available for replay on the company’s website. The slide presentation used for the event is provided as Exhibit 99.1 and is furnished under a non‑filing status, meaning it is not treated as part of the company’s formal financial statements.
Brad Williams, President of Cadre Holdings, Inc. (ticker: CDRE), reported a sale of 4,132 shares of the company's common stock on 09/23/2025 at a price of $37 per share. Following the reported transaction, the reporting person beneficially owned 114,353 shares. The Form 4 states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025, and the filing was signed on September 25, 2025.
Cadre Holdings, Inc. (CDRE) filed a Form 144 reporting a proposed Rule 144 sale of common stock. The filing states a broker (UBS Financial Services, Inc., New York) is named to sell 4,132 shares with an aggregate market value of $152,884, representing a very small fraction of the issuer's reported 40,663,844 outstanding shares. The securities were acquired as restricted stock units (RSUs) on 03/09/2024 and 03/13/2024 and the filer reports no sales in the prior three months. The notice includes the standard attestation regarding material nonpublic information and Rule 10b5-1 plan language.
Cadre Holdings, Inc. (CDRE) filed a Form 144 reporting a proposed Rule 144 sale of common stock. The filing states a broker (UBS Financial Services, Inc., New York) is named to sell 4,132 shares with an aggregate market value of $152,884, representing a very small fraction of the issuer's reported 40,663,844 outstanding shares. The securities were acquired as restricted stock units (RSUs) on 03/09/2024 and 03/13/2024 and the filer reports no sales in the prior three months. The notice includes the standard attestation regarding material nonpublic information and Rule 10b5-1 plan language.
Cadre Holdings' Schedule 13G/A shows that Warren B. Kanders beneficially owns 11,823,511 shares of common stock, representing 28.9% of the class. The total includes 10,216,192 shares held by Kanders SAF, LLC (reported as 25%), 1,305,650 shares in a Roth IRA, 45,584 shares held personally, and 232,635 shares underlying options that are exercisable or exercisable within 60 days and therefore counted. The filing also discloses excluded awards: 229,797 options not currently exercisable and 2,071,481 restricted stock awards not vested or vesting within 60 days. Mr. Kanders is shown with sole voting and dispositive power over 11,800,061 shares and shared voting/dispositive power over 23,450 shares.